Pragma Bio (former VastBiome)

Mining the molecules that matter.

San Francisco, United States · Founded 2019 · $14.5M raised

Employees
11–50
Founded
2019
Total Funding
$14.5M
Last Round
$10.0M Series AMar 2023
Rounds
2

About

Pragma Bio (formerly VastBiome) is a biotechnology company discovering new medicines using a biology-first, AI-enabled approach that mines gut-derived small molecules for therapeutic potential. The company's proprietary PIKASO platform uses bioinformatics and AI to identify Biosynthetic Gene Clusters (BGCs) from the gut microbiome, then applies synthetic biology and medicinal chemistry to make and test novel small molecules targeting the gut-immune axis. Pragma Bio focuses on immunological disorders and applies phenotypic screening to uncover new disease-modifying pathways and de-risk efficacy early in development.

Summary

Pragma Bio (former VastBiome) is a Healthcare company based in San Francisco, United States, founded in 2019. It has raised $14.5M in total across 2 rounds, most recently a $10.0M Series A round in Mar 2023.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series ASeries AMar 2023
$10.0M

Sign up to see all 2 rounds

Seed through Series A — per-round amounts, valuations, and who invested in each round.

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Pragma Bio (former VastBiome) on Indexed.vc
<a href="https://indexed.vc/companies/pragma-bio-former-vastbiome"><img src="https://indexed.vc/api/badge/company/pragma-bio-former-vastbiome" alt="Pragma Bio (former VastBiome) on Indexed.vc" width="260" height="76" /></a>